Publications of B. Lutz

Jacob, W.; Marsch, R.; Marsicano, G.; Lutz, B.; Wotjak, C. T.: Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo. Neurobiology of Learning and Memory 98 (1), pp. 47 - 55 (2012)

Jacob, W.; Yassouridis, A.; Marsicano, G.; Monory, K.; Lutz, B.; Wotjak, C. T.: Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain and Behavior 8 (7), pp. 685 - 698 (2009)

Kamprath, K.; Plendl, W.; Marsicano, G.; Deussing, J. M.; Wurst, W.; Lutz, B.; Wotjak, C. T.: Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling. Genes Brain and Behavior 8 (2), pp. 203 - 211 (2009)

Sitz, J. H.; Baumgärtel, K.; Hämmerle, B.; Papadopoulos, C.; Hekerman, P.; Tejedor, F. J.; Becker, W.; Lutz, B.: THE DOWN SYNDROME CANDIDATE DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A PHOSPHORYLATES THE NEURODEGENERATION-RELATED SEPTIN 4. Neuroscience 157 (3), pp. 596 - 605 (2008)

Steiner, M. A.; Marsicano, G.; Wotjak, C. T.; Lutz, B.: Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 33 (8), pp. 1165 - 1170 (2008)

Hansen, H. H.; Krutz, B.; Sifringer, M.; Stefovska, V.; Bittigau, P.; Pragst, F.; Marsicano, G.; Lutz, B.; Ikonomidou, C.: Cannabinolds enhance susceptibility of immature brain to ethanol neurotoxicity. Annals of Neurology 64 (1), pp. 42 - 52 (2008)

Azad, S. C.; Kurz, J.; Marsicano, G.; Lutz, B.; Zieglgänsberger, W.; Rammes, G.: Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learning & Memory 15 (3), pp. 143 - 152 (2008)

Izzo, A. A.; Aviello, G.; Petrosino, S.; Orlando, P.; Marsicano, G.; Lutz, B.; Borrelli, F.; Capasso, R.; Nigam, S.; Capasso, F. et al.; Di Marzo, V.: Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. Journal of Molecular Medicine-JMM 86 (1), pp. 89 - 98 (2008)

Steiner, M. A.; Wanisch, K.; Monory, K.; Marsicano, G.; Borroni, E.; Bächli, H.; Holsboer, F.; Lutz, B.; Wotjak, C. T.: Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. The Pharmacogenomics Journal 8 (3), pp. 196 - 208 (2008)

Monory, K.; Blaudzun, H.; Massa, F.; Kaiser, N.; Lemberger, T.; Schtuz, G.; Wotjak, C. T.; Lutz, B.; Marsicano, G.: Genetic dissection of behavioural and autonomic effects of Delta 9-Tetrahydrocannabinol in mice. PLoS Biology 5 (10), pp. 2354 - 2368 (2007)

Steiner, M.; Marsicano, G.; Nestler, E. J.; Holsboer, F.; Lutz, B.; Wotjak, C. T.: Endocannabinoid signaling modulates HPA axis activity in the mouse - implications for depression disorders. Pharmacopsychiatry 40 (5), p. 217 - 217 (2007)

Cota, D.; Steiner, M. A.; Marsicano, G.; Cervino, C.; Herman, J. P.; Grübler, Y.; Stalla, J.; Pasquali, R.; Lutz, B.; Stalla, G. K. et al.; Pagotto, U.: Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 148 (4), pp. 1574 - 1581 (2007)

Brenz Verca, M. S.; Weber, P.; Mayer, C.; Graf, C.; Refojo, D.; Kuhn, R.; Grummt, I.; Lutz, B.: Development of a species-specific RNA polymerase I-based shRNA expression vector. Nucleic Acids Research 35 (2), doi: 10.1093/nar/gkl1045, p. e10 - e10 (2007)

Marsch, R.; Foeller, E.; Rammes, G.; Bunck, M.; Kössl, M.; Holsboer, F.; Zieglgänsberger, W.; Landgraf, R.; Lutz, B.; Wotjak, C. T.: Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. The Journal of Neuroscience 27 (4), pp. 832 - 839 (2007)

Steiner, M.; Marsicano, G.; Holsboer, F.; Lutz, B.; Wotjak, C. T.: Cannabinoid receptor 1 (CB1) signaling acts as a major regulatory mechanism of hypothalamus-pituitary-adrenal (HPA) axis mediated corticosterone secretion. Frontiers in Neuroendocrinology 27 (1), p. 39 - 39 (2006)

Steiner, M. A.; Wanisch, K.; Borroni, E.; Marsicano, G.; Holsboer, F.; Wotjak, C. T.; Lutz, B.: Genetic knockout and pharmacological blockade of cannabinoid receptor I affect stress coping behaviours in the mouse forced swim test. Biological Psychiatry 59 (8, Suppl. S), p. 163S - 163S (2006)

Aguado, T.; Palazuelos, J.; Monory, K.; Stella, N.; Cravatt, B.; Lutz, B.; Marsicano, G.; Kokaia, Z.; Guzman, M.; Galve-Roperh, I.: The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. Journal of Neuroscience 26 (5), pp. 1551 - 1561 (2006)

Massa, F.; Sibaev, A.; Marsicano, G.; Blaudzun, H.; Storr, M.; Lutz, B.: Vanilloid receptor (TRPV1)-deficient mice show increased susceptibility to dinitrobenzene sulfonic acid induced colitis. Journal of Molecular Medicine-JMM 84 (2), pp. 142 - 146 (2006)

Domenici, M. R.; Azad, S. C.; Marsicano, G.; Schierloh, A.; Wotjak, C. T.; Dodt, H.-U.; Zieglgänsberger, W.; Lutz, B.; Rammes, G.: Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamergic synaptic transmission. The Journal of Neuroscience 26 (21), pp. 5794 - 5799 (2006)

Kamprath, K.; Marsicano, G.; Tang, J.; Monory, K.; Bisogno, T.; Di Marzo, V.; Lutz, B.; Wotjak, C. T.: Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. The Journal of Neuroscience 26 (25), pp. 6677 - 6686 (2006)